Contact person
Jørgen Søberg Petersen, Partner
Go to profile

Hemab Therapeutics

Investment area
Seed Investments
Region
Europe
Date of investment
February 2023
Website
https://hemab.com/

Hemab is a clinical-stage biotech company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.

Contact person
Jørgen Søberg Petersen, Partner
Go to profile

Hemab Therapeutics

Investment area
Seed Investments
Region
Europe
Date of investment
February 2023
Website
https://hemab.com/

Hemab is a clinical-stage biotech company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.

Hemab Therapeutics

Investment area
Seed Investments
Region
Europe
Date of investment
February 2023
Website
Visit their website

Hemab is a clinical-stage biotech company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.

Contact person
Jørgen Søberg Petersen, Partner
Go to profile